Lacticaseibacillus rhamnosus HN001

Introduction

Microbiology
Profile
  • Gram positive
  • Non spore former
  • Anaerobic bacteria
    		•
    no img yet
    Lacticaseibacillus rhamnosus HN001
    Functions
  • Modulation of intestinal microbiota
  • Strengthen immunity
    		•
    Origin First found in human gut.
    Genome GenBank

    Functional Studies

    Clinical Trials or Animal Experiments
    ID Category Subject Title Year
    1 clinical trial modulate gut microbiota Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study 2017
    2 clinical trial gestational diabetes mellitus (GDM) Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial 2017
    3 clinical trial irritable bowel syndrome (IBS) Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients 2020
    4 clinical trial psychological wellbeing Probiotics for Reduction of Examination Stress in Students (PRESS) study: A randomized, double-blind, placebo-controlled trial of the probiotic Lacticaseibacillus rhamnosus HN001 2022
    5 clinical trial S. aureus infections Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study 2018
    6 clinical trial immunity Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001 2001
    7 clinical trial eczema Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT 2019
    8 clinical trial modulate gut microbiota Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly 2012
    9 clinical trial peri-implant mucositis Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: A randomized controlled trial 2022
    10 clinical trial urogenital tract health Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study 2015
    11 clinical trial immunity Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection 2008
    12 clinical trial eczema A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial 2008
    13 clinical trial S. aureus infections Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus 2017
    14 animal experiment Salmonella infections Effects of Bifidobacterium longum Subsp. infantis CECT 7210 and Lactobacillus rhamnosus HN001, Combined or Not With Oligofructose-Enriched Inulin, on Weaned Pigs Orally Challenged With Salmonella Typhimurium 2012
    15 animal experiment immunity Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) 2000
    16 animal experiment modulate gut microbiota, immunity Postnatal Administration of Lactobacillus rhamnosus HN001 Ameliorates Perinatal Broad-Spectrum Antibiotic-Induced Reduction in Myelopoiesis and T Cell Activation in Mouse Pups 2018
    17 animal experiment immunity Effects of the Administration of Bifidobacterium longum subsp. infantis CECT 7210 and Lactobacillus rhamnosus HN001 and Their Synbiotic Combination With Galacto-Oligosaccharides Against Enterotoxigenic Escherichia coli F4 in an Early Weaned Piglet Model 2021
    18 animal experiment immunity Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice 2002
    19 animal experiment immunity Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice 2001
    20 animal experiment immunity Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice 2002

    Links (further search of Lacticaseibacillus rhamnosus HN001)